Generics makers lost $8.5 billion in value Thursday on news that the feds are prepping price-fixing charges against industry players. The good news: Though the…

Share prices for leading generics companies took a big hit Thursday on news that the Department of Justice could file collusion charges by year’s end, a probe…

Another day, another Valeant asset sale rumor. Less than 24 hours after Valeant and Takeda's Salix deal talks surfaced, the embattled drugmaker is…

For pharma and a former Warner Chilcott manager, it could have been much worse. Ex-district manager Landon Eckles was sentenced to 1 year of probation and a…

Valeant's business relationships with its distributors are under scrutiny once again, with the latest probe focusing on the remarkable sales performance…

Pfizer’s divide-and-conquer approach to Lyrica in the U.K. just hit a wall. The Court of Appeal upheld a ruling that struck down a key patent on Lyrica and…

In what may be a record speed for a Justice Department settlement, Mylan has cut a deal to pay $465 million to resolve allegations that it overcharged Medicaid…

Mylan did overcharge Medicaid for EpiPen for years, investigators now say--more and more so as the company jacked up prices. How much might Mylan have to pay…

Legal